Roche Holding AG (RHHBY)
57.47
-0.63
(-1.08%)
USD |
OTCM |
Aug 24, 16:00
Roche Price : 57.47 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 57.48 | 57.72 | 57.40 | 57.47 | 1.725M |
| Aug 21, 2026 | 57.37 | 58.60 | 57.37 | 58.10 | 3.291M |
| Aug 20, 2026 | 57.94 | 58.28 | 57.00 | 57.25 | 5.374M |
| Aug 19, 2026 | 56.47 | 58.41 | 56.47 | 58.20 | 2.203M |
| Aug 18, 2026 | 55.30 | 55.73 | 55.21 | 55.52 | 4.587M |
| Aug 17, 2026 | 54.87 | 55.43 | 54.55 | 54.61 | 1.843M |
| Aug 14, 2026 | 54.60 | 54.88 | 54.42 | 54.52 | 1.477M |
| Aug 13, 2026 | 56.19 | 56.22 | 55.38 | 55.49 | 2.552M |
| Aug 12, 2026 | 55.75 | 56.52 | 55.70 | 56.51 | 992141.0 |
| Aug 11, 2026 | 57.50 | 57.71 | 56.56 | 56.62 | 1.919M |
| Aug 10, 2026 | 57.09 | 57.62 | 57.06 | 57.43 | 1.028M |
| Aug 07, 2026 | 57.44 | 57.57 | 56.97 | 57.26 | 1.356M |
| Aug 06, 2026 | 56.77 | 56.86 | 55.96 | 56.17 | 743897.0 |
| Aug 05, 2026 | 56.13 | 56.63 | 55.96 | 56.41 | 4.050M |
| Aug 04, 2026 | 55.69 | 55.82 | 55.18 | 55.42 | 1.260M |
| Aug 03, 2026 | 55.13 | 55.27 | 54.48 | 55.08 | 988259.0 |
| Jul 31, 2026 | 54.75 | 55.00 | 54.18 | 54.67 | 1.112M |
| Jul 30, 2026 | 54.25 | 55.34 | 54.15 | 55.27 | 1.240M |
| Jul 29, 2026 | 55.73 | 57.00 | 54.70 | 54.97 | 3.300M |
| Jul 28, 2026 | 55.50 | 56.57 | 55.47 | 56.52 | 2.765M |
| Jul 27, 2026 | 54.93 | 55.48 | 54.71 | 54.77 | 3.164M |
| Jul 24, 2026 | 54.48 | 54.84 | 54.06 | 54.70 | 3.512M |
| Jul 23, 2026 | 52.06 | 54.02 | 51.99 | 53.92 | 3.377M |
| Jul 22, 2026 | 51.81 | 51.84 | 51.00 | 51.70 | 1.191M |
| Jul 21, 2026 | 50.82 | 51.48 | 50.64 | 51.14 | 1.568M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novartis AG | 158.02 |
| Eli Lilly & Co. | 1246.93 |
| AstraZeneca PLC | 166.71 |
| Merck & Co., Inc. | 150.66 |
| Pfizer Inc. | 27.97 |
Price Related Metrics
| PE Ratio | 23.78 |
| PS Ratio | 4.818 |
| PEG Ratio | 0.7977 |
| Price to Free Cash Flow | 22.61 |
| Earnings Yield | 4.21% |
| Market Cap | 317.27B |
| PEGY Ratio | 0.7316 |
| Operating PE Ratio | 15.71 |
| Normalized PE Ratio | 19.92 |